205 related articles for article (PubMed ID: 8979202)
1. Endometrial biopsy in DUB.
Ash SJ; Farrell SA; Flowerdew G
J Reprod Med; 1996 Dec; 41(12):892-6. PubMed ID: 8979202
[TBL] [Abstract][Full Text] [Related]
2. Clinical pathway for evaluating women with abnormal uterine bleeding.
Dunn TS; Stamm CA; Delorit M; Goldberg G
J Reprod Med; 2001 Sep; 46(9):831-4. PubMed ID: 11584486
[TBL] [Abstract][Full Text] [Related]
3. Study of endometrial tissue in dysfunctional uterine bleeding.
Kayastha S
Nepal Med Coll J; 2013 Mar; 15(1):27-30. PubMed ID: 24592789
[TBL] [Abstract][Full Text] [Related]
4. Predicting endometrial cancer among older women who present with abnormal vaginal bleeding.
Feldman S; Cook EF; Harlow BL; Berkowitz RS
Gynecol Oncol; 1995 Mar; 56(3):376-81. PubMed ID: 7705671
[TBL] [Abstract][Full Text] [Related]
5. Abnormal uterine bleeding.
Albers JR; Hull SK; Wesley RM
Am Fam Physician; 2004 Apr; 69(8):1915-26. PubMed ID: 15117012
[TBL] [Abstract][Full Text] [Related]
6. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
[TBL] [Abstract][Full Text] [Related]
7. Payer cost savings with endometrial ablation therapy.
London R; Holzman M; Rubin D; Moffitt B
Am J Manag Care; 1999 Jul; 5(7):889-97. PubMed ID: 10557409
[TBL] [Abstract][Full Text] [Related]
8. Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding.
Litta P; Merlin F; Saccardi C; Pozzan C; Sacco G; Fracas M; Capobianco G; Dessole S
Maturitas; 2005 Feb; 50(2):117-23. PubMed ID: 15653009
[TBL] [Abstract][Full Text] [Related]
9. The value of routine endometrial biopsy in gynaecological practice in Nigeria.
Adewole IF; Babarinsa IA; Akang EE; Thompson MO
West Afr J Med; 1997; 16(4):242-5. PubMed ID: 9473961
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting adequacy of Pipelle and Tao Brush endometrial sampling.
Williams AR; Brechin S; Porter AJ; Warner P; Critchley HO
BJOG; 2008 Jul; 115(8):1028-36. PubMed ID: 18651884
[TBL] [Abstract][Full Text] [Related]
11. Five-year follow-up of patients with recurrent postmenopausal bleeding.
Twu NF; Chen SS
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):628-33. PubMed ID: 10969449
[TBL] [Abstract][Full Text] [Related]
12. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound, hysteroscopy and endometrial biopsy in the investigation of endometrial cancer.
Symonds I
Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):381-91. PubMed ID: 11476560
[TBL] [Abstract][Full Text] [Related]
14. Cytohistologic correlation in patients with clinical symptoms of postmenopausal bleeding.
Webster SD; Cason Z; Lemos LB; Benghuzzi H
Biomed Sci Instrum; 2000; 36():367-72. PubMed ID: 10834260
[TBL] [Abstract][Full Text] [Related]
15. Endometrial brush biopsy for the diagnosis of endometrial cancer.
Del Priore G; Williams R; Harbatkin CB; Wan LS; Mittal K; Yang GC
J Reprod Med; 2001 May; 46(5):439-43. PubMed ID: 11396369
[TBL] [Abstract][Full Text] [Related]
16. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding.
Garcia F; Barker B; Davis J; Shelton T; Harrigill K; Schalk N; Meyer J; Hatch K
J Reprod Med; 2003 Nov; 48(11):882-8. PubMed ID: 14686021
[TBL] [Abstract][Full Text] [Related]
17. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding.
Lasmar RB; Barrozo PR; de Oliveira MA; Coutinho ES; Dias R
J Minim Invasive Gynecol; 2006; 13(5):409-12. PubMed ID: 16962523
[TBL] [Abstract][Full Text] [Related]
18. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
Ozalp S; Kabukcuoglu S; Tanir HM
Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
[TBL] [Abstract][Full Text] [Related]
19. Endometrial hormone receptors in women with dysfunctional uterine bleeding.
Chakraborty S; Khurana N; Sharma JB; Chaturvedi KU
Arch Gynecol Obstet; 2005 Jun; 272(1):17-22. PubMed ID: 15300446
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding.
Farquhar CM; Lethaby A; Sowter M; Verry J; Baranyai J
Am J Obstet Gynecol; 1999 Sep; 181(3):525-9. PubMed ID: 10486458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
